论中国耐药结核病防治的可持续发展  

Sustainable development for prevention and treatment of drug resistant tuberculosis in China

作　　者：陆伟[1] 傅衍勇 LU Wei FU Yan-yong(Department of Chronic and Communicable Disease Control and Prevention ,Jiangsu Center for Disease Control and Preven- tion, Nanjing 210009, China)

机构地区：[1]江苏省疾病预防控制中心慢性传染病防治所,南京210009 [2]天津市结核病控制中心

出　　处：《结核病与肺部健康杂志》2016年第4期262-266,共5页Journal of Tuberculosis and Lung Health

基　　金：中国卫生部科研基金(W201208)

摘　　要：我国位列耐药结核病高负担国家的第二位.目前,耐多药结核病防治工作已取得了积极进展并初显成效,但疫情仍相当严峻,必须加大政策开发和经费投入,提高保障和救助的水平,积极推广新技术并提高高危人群检测覆盖面,优化防控策略,才能保证耐药结核病控制的可持续发展.China ranked second among high-burden drug-resistant countries. Currently, drug-resistant tuber- culosis is still a serious problem in China despite many achievements of drug-resistant TB control have been made. To maintain the sustainable development of drug-resistant TB control, we should strengthen policy development and funding input, improve medical insurance system, promote new diagnostic technology and improve the screening coverage and optimize control strategy actively.

关 键 词：结核 抗多种药物性 预防卫生服务 结果与过程评价(卫生保健) 

分 类 号：R52[医药卫生—内科学]